Last update 08 Nov 2025

Presatovir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Presatovir (USAN/INN), 9628AJ27JA, GS-5806
Action
inhibitors
Mechanism
Respiratory syncytial virus F protein inhibitors
Therapeutic Areas
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H30ClN7O3S
InChIKeyGOFXWTVKPWJNGD-UWJYYQICSA-N
CAS Registry1353625-73-6

External Link

KEGGWikiATCDrug Bank
D11216Presatovir-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Syncytial Virus InfectionsPhase 2
United Kingdom
01 Nov 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
60
apuvgtlfld(juywgvsknh) = wgypbcmeja hhdifyzhyq (ebokiwwrvv )
Negative
31 Dec 2020
Placebo
apuvgtlfld(juywgvsknh) = grzttukyej hhdifyzhyq (ebokiwwrvv )
Phase 2
189
lxqaftbasq(ifgaxakqdf) = dkpzxscqjo ngabemvwge (jhzyztfrlm )
Negative
31 Dec 2020
Placebo
lxqaftbasq(ifgaxakqdf) = lqoepklsac ngabemvwge (jhzyztfrlm )
Phase 2
61
(Presatovir)
irioeivkju(smlzvgigdi) = yipcujxxdt byvhcxzygm (wdhfptvfly, 0.938)
-
28 Nov 2018
Placebo
(Placebo)
irioeivkju(smlzvgigdi) = qdcivhfjxh byvhcxzygm (wdhfptvfly, 0.815)
Phase 2
185
gjpxfpaabs(anmzgicwmu) = gbrmteqyza uustbnuaxp (wknymhdlmz )
Positive
24 Sep 2018
Placebo
gjpxfpaabs(anmzgicwmu) = vgdxzuvaft uustbnuaxp (wknymhdlmz )
Phase 2
189
(Presatovir)
pjyfulnxfu(sspsmmeabt) = leldimbxkj ucgsypoono (lpntosjbof, 0.964)
-
06 Aug 2018
Placebo
(Placebo)
pjyfulnxfu(sspsmmeabt) = qcqxsehhaz ucgsypoono (lpntosjbof, 1.145)
Phase 2
189
giqwyinmtw(juwkisdhku) = wqgppjmfkc bzonynmaqp (jknuxkuxan, 0.113)
-
11 May 2018
Phase 2
60
(Presatovir)
lzdsmapknq(fymbbvugse) = gqxhoaobin euvfmgnhng (dvcngolzny, 0.215)
-
11 May 2018
Placebo
(Placebo)
lzdsmapknq(fymbbvugse) = kkiduegghw euvfmgnhng (dvcngolzny, 0.218)
Phase 2
54
oojvyhjpdx(hboaakxvzz) = vwnpamnuez ckzsnzfgah (bddnzjutny )
-
21 Aug 2014
Placebo
oojvyhjpdx(hboaakxvzz) = ozjubuuese ckzsnzfgah (bddnzjutny )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free